PriceTargets.com logo

Leerink Partnrs Stock Recommendations and Price Targets

This is a list of recent ratings by Leerink Partnrs.

DateCompany NameActionCurrent
Price		Price
Target		RatingImpact on
Share Price
11/15/2024
CMPX
Compass Therapeutics
 Downgrade$1.00Strong-Buy ➝ HoldN/A
11/13/2024
MASS
908 Devices
 Downgrade$2.00Strong-Buy ➝ HoldN/A
11/12/2024
BMY
Bristol-Myers Squibb
 Upgrade$56.00Hold ➝ Strong-BuyN/A
11/7/2024
ZYME
Zymeworks
 Upgrade$15.00Hold ➝ Strong-BuyN/A
11/7/2024
XRAY
DENTSPLY SIRONA
 Downgrade$18.00Strong-Buy ➝ HoldN/A
11/6/2024
BEAM
Beam Therapeutics
 Upgrade$24.00Hold ➝ Strong-BuyN/A
11/5/2024
IDYA
IDEAYA Biosciences
 Downgrade$27.00Strong-Buy ➝ HoldLow
11/4/2024
ZURA
Zura Bio
 Upgrade$3.00Strong-BuyHigh
10/31/2024
NVST
Envista
 Upgrade$21.00Strong Sell ➝ HoldMedium
10/24/2024
TENX
Tenax Therapeutics
 Upgrade$5.00Strong-BuyHigh
10/21/2024
GILD
Gilead Sciences
 Upgrade$88.00Hold ➝ Strong-BuyHigh
10/16/2024
VYGR
Voyager Therapeutics
 Upgrade$6.00Strong-BuyMedium
10/11/2024
MNMD
Mind Medicine (MindMed)
 Upgrade$8.00Strong-BuyMedium
10/11/2024
STOK
Stoke Therapeutics
 Upgrade$12.00Strong-BuyLow
10/7/2024
MOLN
Molecular Partners
 Upgrade$5.00Strong-BuyLow
10/2/2024
HUM
Humana
 Downgrade$276.00Strong-Buy ➝ HoldMedium
9/27/2024
AGIO
Agios Pharmaceuticals
 Downgrade$54.00Strong-Buy ➝ HoldMedium
9/24/2024
REGN
Regeneron Pharmaceuticals
 Downgrade$757.00Strong-Buy ➝ HoldMedium
9/18/2024
ICLR
ICON Public
 Upgrade$190.00Strong-BuyLow
9/17/2024
ORKA
Oruka Therapeutics
 Upgrade$24.00Strong-BuyLow
9/12/2024
FULC
Fulcrum Therapeutics
 Downgrade$3.00Strong-Buy ➝ HoldHigh
9/9/2024
IMUX
Immunic
 Upgrade$1.00Strong-BuyHigh
9/9/2024
TRVI
Trevi Therapeutics
 Upgrade$3.00Strong-BuyMedium
9/9/2024
IRWD
Ironwood Pharmaceuticals
 Upgrade$4.00HoldMedium
9/9/2024
GERN
Geron
 Upgrade$4.00Strong-BuyLow
9/9/2024
MNKD
MannKind
 Upgrade$7.00Strong-BuyMedium
9/9/2024
PLRX
Pliant Therapeutics
 Upgrade$12.00Strong-BuyLow
9/9/2024
PRTC
PureTech Health
 Upgrade$23.00Strong-BuyHigh
9/9/2024
GLPG
Galapagos
 Upgrade$27.00HoldMedium
9/9/2024
KYMR
Kymera Therapeutics
 Upgrade$42.00Strong-BuyMedium
9/3/2024
TXG
10x Genomics
 Upgrade$13.00Strong-BuyLow
9/3/2024
NARI
Inari Medical
 Upgrade$51.00HoldLow
9/3/2024
PEN
Penumbra
 Upgrade$238.00Strong-BuyLow
8/12/2024
ARDT
Ardent Health Partners
 Upgrade$17.00Strong-BuyLow
8/12/2024
ARCT
Arcturus Therapeutics
 Upgrade$16.00Strong-BuyLow
8/7/2024
PGNY
Progyny
 Downgrade$14.00Strong-Buy ➝ HoldLow
8/6/2024
TBPH
Theravance Biopharma
 Downgrade$10.00Strong-Buy ➝ HoldLow
8/1/2024
RCM
R1 RCM
 Downgrade$14.00Strong-Buy ➝ HoldLow
8/1/2024
WAT
Waters
 Upgrade$358.00Hold ➝ Strong-BuyLow
7/24/2024
TECX
Tectonic Therapeutic
 Upgrade$40.00Strong-BuyLow
7/24/2024
IONS
Ionis Pharmaceuticals
 Upgrade$34.00Hold ➝ Strong-BuyLow
7/23/2024
ALMS
Alumis
 Upgrade$9.00Strong-BuyLow
7/22/2024
BNTC
Benitec Biopharma
 Upgrade$11.00Strong-BuyLow
7/22/2024
CELC
Celcuity
 Upgrade$13.00Strong-BuyLow
7/10/2024
EHC
Encompass Health
 Upgrade$99.00Strong-BuyLow
7/9/2024
HLVX
HilleVax
 Downgrade$2.00Strong-Buy ➝ HoldLow
7/8/2024
RVTY
Revvity
 Upgrade$110.00Strong-BuyLow
7/2/2024
SDGR
Schrödinger
 Upgrade$19.00Strong-BuyLow
6/24/2024
SLDB
Solid Biosciences
 Upgrade$5.00Hold ➝ Strong-BuyLow
5/21/2024
QTTB
Q32 Bio
 Upgrade$33.00Strong-BuyLow
5/14/2024
BOLT
Bolt Biotherapeutics
 Downgrade$1.00Strong-Buy ➝ HoldLow
5/14/2024
AIRS
AirSculpt Technologies
 Downgrade$7.00Strong-Buy ➝ HoldLow
5/14/2024
EHAB
Enhabit
 Upgrade$7.00Strong Sell ➝ HoldLow
5/10/2024
AQST
Aquestive Therapeutics
 Upgrade$4.00Strong-BuyLow
5/8/2024
MYGN
Myriad Genetics
 Upgrade$15.00Market Perform ➝ OutperformLow
5/6/2024
BPMC
Blueprint Medicines
 Upgrade$89.00Underperform ➝ Market PerformLow
5/1/2024
CVS
CVS Health
 Downgrade$53.00Outperform ➝ Market PerformLow
4/30/2024
LXRX
Lexicon Pharmaceuticals
 Reiterated Rating$1.00OutperformLow
4/29/2024
XOMA
XOMA
 Reiterated Rating$30.00OutperformLow
4/29/2024
NGNE
Neurogene
 Reiterated Rating$35.00OutperformLow
4/29/2024
IMCR
Immunocore
 Reiterated Rating$32.00OutperformLow
4/25/2024
CVAC
CureVac
 Downgrade$3.00Outperform ➝ Market PerformLow
4/25/2024
TNDM
Tandem Diabetes Care
 Upgrade$27.00Market Perform ➝ OutperformLow
4/23/2024
RNAC
Cartesian Therapeutics
 Reiterated Rating$17.00OutperformLow
4/16/2024
ANAB
AnaptysBio
 Reiterated Rating$19.00OutperformLow
4/15/2024
MNMD
Mind Medicine (MindMed)
 Reiterated Rating$8.00OutperformLow
4/15/2024
LENZ
LENZ Therapeutics
 Reiterated Rating$33.00OutperformLow
4/5/2024
ARDX
Ardelyx
 Reiterated Rating$5.00OutperformLow
4/3/2024
LRMR
Larimar Therapeutics
 Reiterated Rating$7.00OutperformLow
4/1/2024
NUVL
Nuvalent
 Upgrade$87.00Market Perform ➝ OutperformLow
3/25/2024
SGMT
Sagimet Biosciences
 Reiterated Rating$5.00OutperformLow
3/18/2024
RGLS
Regulus Therapeutics
 Reiterated Rating$1.00OutperformLow
3/14/2024
SPRB
Spruce Biosciences
 Downgrade$0.00Outperform ➝ Market PerformLow
3/11/2024
AMLX
Amylyx Pharmaceuticals
 Downgrade$5.00Outperform ➝ Market PerformLow
3/6/2024
RGNX
REGENXBIO
 Upgrade$10.00Market Perform ➝ OutperformLow
3/5/2024
SPRY
ARS Pharmaceuticals
 Upgrade$14.00Market Perform ➝ OutperformLow
3/4/2024
KYTX
Kyverna Therapeutics
 Reiterated Rating$4.00OutperformLow
2/26/2024
GDRX
GoodRx
 Reiterated Rating$4.00OutperformLow
2/26/2024
HIMS
Hims & Hers Health
 Reiterated Rating$19.00Market PerformLow
2/26/2024
ACCD
Accolade
 Reiterated Rating$3.00OutperformLow
2/26/2024
RCM
R1 RCM
 Reiterated Rating$14.00OutperformLow
2/26/2024
TDOC
Teladoc Health
 Reiterated Rating$9.00Market PerformLow
2/26/2024
CERT
Certara
 Reiterated Rating$10.00Market PerformLow
2/26/2024
WBA
Walgreens Boots Alliance
 Reiterated Rating$8.00Market PerformLow
2/26/2024
PINC
Premier
 Reiterated Rating$22.00Market PerformLow
2/26/2024
NVST
Envista
 Reiterated Rating$21.00UnderperformLow
2/26/2024
OMI
Owens & Minor
 Reiterated Rating$12.00Market PerformLow
2/26/2024
DOCS
Doximity
 Reiterated Rating$49.00Market PerformLow
2/26/2024
PDCO
Patterson Companies
 Reiterated Rating$20.00OutperformLow
2/26/2024
XRAY
DENTSPLY SIRONA
 Reiterated Rating$18.00OutperformLow
2/26/2024
PGNY
Progyny
 Reiterated Rating$14.00OutperformLow
2/26/2024
CVS
CVS Health
 Reiterated Rating$53.00OutperformLow
2/26/2024
HSIC
Henry Schein
 Reiterated Rating$69.00Market PerformLow
2/26/2024
CAH
Cardinal Health
 Reiterated Rating$119.00OutperformLow
2/26/2024
DGX
Quest Diagnostics
 Reiterated Rating$160.00Market PerformLow
2/26/2024
LH
Laboratory Co. of America
 Reiterated Rating$235.00OutperformLow
2/26/2024
COR
Cencora
 Reiterated Rating$240.00OutperformLow
2/26/2024
IQV
IQVIA
 Reiterated Rating$193.00OutperformLow
2/26/2024
ALGN
Align Technology
 Reiterated Rating$224.00Market PerformLow
2/26/2024
MCK
McKesson
 Reiterated Rating$606.00OutperformLow